PT-141 (Bremelanotide).
FDA-approved peptide for female sexual dysfunction A prescription peptide, given by injection, that acts on melanocortin receptors in the brain to support desire and arousal. The action is central rather than on blood vessels.
Reviewed March 2026
- Category
- Peptide
- Also filed under
- Sexual FunctionLibidoArousal
What PT-141 (Bremelanotide) is, and what it does.
- Does it work
- Suits adults working with a clinician on low desire, since it's a prescription medicine. Blood pressure gets checked first, because it shifts autonomic tone for a few hours.
- How much to take
- The band on record is 0.5mg to 1.8mg by subcutaneous injection, since a swallowed peptide is cleaved before absorption. It's a prescription medicine, so a clinician sets the dose.
- Time to feel it
- Roughly 45 minutes to a few hours after a dose. The pharmacology is episodic and short-lived, so there's no build-up phase to sit through.
- The first dose
- Flushing and nausea are the most commonly recorded effects in the first hours. Blood pressure rises briefly while heart rate falls, then both settle.
- With regular use
- Most effects take 2-8 weeks. Be patient.
- How well tolerated
- Generally well tolerated. Check with your doctor if on medications.
- How it feels
- Flushing and mild nausea are common in the first hour, then a rise in desire over the hours after. It's episodic, so it comes and goes with each dose rather than building.
- The overlooked benefit
- Because it works on brainstem and hypothalamic signalling rather than smooth muscle, it also nudges autonomic tone, which is why blood pressure is checked before use.
0.5 to 1.8mg a day is where PT-141 (Bremelanotide) works.
Source: Kingsberg et al., 2019; FDA approval data
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
PT-141 (Bremelanotide) has emerging evidence. Based on 7+ studies.
- sexual desire and arousal in womenRandomised trial
- central MC4 receptor agonism in the hypothalamusNarrative review
- transient rise in blood pressure with a fall in heart rate after a doseRandomised trial
- skin pigmentation change with repeated melanocortin exposureNarrative review
- nausea and flushing as dose-related effectsRandomised trial
Questions people ask about PT-141 (Bremelanotide).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- Honestly, most people would benefit more from the basics. But if you've got a specific reason to try it, the risk is generally low.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Bremelanotide produces a short-lived rise in blood pressure, and yohimbine independently raises noradrenaline through alpha-2 blockade. Together the effect on normal blood pressure is larger than with either alone.
Caffeine's adenosine receptor blockade raises catecholamine tone and normal blood pressure slightly. That overlaps with the transient pressor window of a melanocortin agonist.
Bremelanotide acts centrally at melanocortin receptors, while arginine feeds the nitric oxide pathway that governs peripheral vascular tone. The two act at different points of the same physiology rather than on the same target. Arginine can lower blood pressure modestly, which sits against the transient pressor effect described for bremelanotide, so blood pressure is the variable to watch.
Citrulline raises plasma arginine more efficiently than arginine itself and supports nitric oxide dependent vasodilation. Bremelanotide produces a short-lived rise in blood pressure with a fall in heart rate after dosing. Combining a vasodilator with a transient pressor agent makes the net blood pressure response harder to predict, and no combination study is available.
Dietary nitrate lowers systolic blood pressure by a small amount through the nitrate-nitrite-nitric oxide route. Bremelanotide raises blood pressure briefly after injection. The interaction is a blood pressure one and belongs in a review of concurrent products, not in a claim of enhanced effect.
Glycyrrhizin inhibits 11-beta-hydroxysteroid dehydrogenase type 2, causing sodium retention and a rise in blood pressure with sustained intake. Bremelanotide already carries a transient pressor effect and a labelled blood pressure caution. Stacking a chronic pressor botanical onto it is a flag, not a synergy.
Nausea is the most frequently reported effect after a bremelanotide injection, arising centrally rather than from the stomach. Ginger supports normal gastric emptying and is one of the botanicals studied for nausea. Whether it helps with centrally driven nausea specifically has not been tested.
Pyridoxine is a long-standing component of nausea regimens and is a cofactor for the decarboxylases that make dopamine and serotonin. The rationale for pairing it here is symptom management rather than any effect on melanocortin signalling. No study has examined the pair.
Tyrosine is the precursor for dopamine and noradrenaline, and central melanocortin signalling interacts with dopaminergic circuits in the hypothalamus. Tyrosine is also the precursor of the melanin pathway that melanocortin receptor activation drives in skin. Both links are biochemical rather than clinical, so this stays early.
Tongkat ali is studied for support of normal androgen levels, which is an endocrine route entirely separate from bremelanotide's receptor action. Consumers commonly combine the two categories. Nothing has measured them together, and the hormonal claims for tongkat ali are themselves early.
Zinc is required for normal testicular steroidogenesis and for many transcription factors in reproductive tissue, so adequacy matters to the background physiology. Bremelanotide works on central receptors and does not depend on zinc status. Regard this as nutritional adequacy rather than a synergy.
Nothing specific on file for PT-141 (Bremelanotide). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What PT-141 (Bremelanotide) actually does.
It is a lab-made copy of a natural hormone fragment that switches on melanocortin receptors, including the one in the brain that shapes arousal signalling.
Digestive enzymes chop peptides up, so this one is injected rather than swallowed.
It works on brain signalling, not on blood vessels, which is a different route from the familiar vascular drugs.
The same receptor family controls pigment cells, which is why flushing and patches of darker skin can show up.
Getting PT-141 (Bremelanotide) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Review of compounds acting on penile erection groups melanocortin receptor agonists such as bremelanotide with the centrally acting agents, working through brain pathways rather than on penile blood vessels as PDE5 inhibitors do.Review. Albersen et al., 2010 (Expert opinion on emerging drugs). PMID 20415601 ↗
These are the studies our verdict leans on, chosen from the 6 we read for PT-141 (Bremelanotide). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.